Quote:
Originally Posted by spence
[
Well, Canadians would beg to differ...they love their health care. I think polls are usually 85-90% in favor.
I'm not sure the claim that only one drug per class is allowed is accurate. For instance, I found one report that listed % market share of the various statin drugs there.
No different than in the USA.
I think a bigger issue is simply that the big companies are making more profit based decisions than just counting how much money is going into R&D. R&D spending is going down as they focus on better returns.
For a large organization it's probably just not practical to go after niche drugs unless you have a business model built around it. This should encourage growth in small companies to meet low volume needs.
There are a TON of companies like this in the Boston area alone.
-spence
|
Sources please.
If your insurance company won't cover chemo at age 75 for you, ya
betta get another company,you'll be there before ya know it.
BTW, Govt. announced today they want everyones medical records computerized
for Obamacare.
Like they will remain private.
BIG BROTHER at it's best.
Whats next ?????